Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
John Cochran currently holds 50,500 shares of Aquestive Therapeutics, Inc. (AQST), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, John Cochran has been a net neutral trader of AQST stock. They have purchased $0 and sold $0 worth of shares.
John Cochran's most recent insider trade was on Jun 10, 2026, when they sold 50,500 shares at $0.00 per share.
John Cochran serves as Executive at Aquestive Therapeutics, Inc. (AQST). They have executed 7 insider transactions totaling $0 over their tenure at the company.
John Cochran holds the position of Executive at Aquestive Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 6 years and currently hold a stake valued at $0.
John Cochran has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by John Cochran was on Jun 10, 2026, when they purchased $0 worth of AQST shares. This transaction involved 50,500 shares at N/A per share.
John Cochran currently owns 50,500 shares of Aquestive Therapeutics, Inc. (AQST), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of John Cochran's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. John Cochran has 7 Form 4 filings on record as an insider at Aquestive Therapeutics, Inc..
Set alerts for John Cochran and 40,000+ other insiders.